Annual D&A
$23.00 K
+$15.00 K+187.50%
December 31, 2023
Summary
- As of February 7, 2025, ATOS annual depreciation & amortization is $23.00 thousand, with the most recent change of +$15.00 thousand (+187.50%) on December 31, 2023.
- During the last 3 years, ATOS annual D&A has fallen by -$24.00 thousand (-51.06%).
- ATOS annual D&A is now -95.21% below its all-time high of $480.30 thousand, reached on December 31, 2014.
Performance
ATOS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$4000.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, ATOS quarterly depreciation & amortization is $4000.00, unchanged on September 30, 2024.
- Over the past year, ATOS quarterly D&A has increased by +$1000.00 (+33.33%).
- ATOS quarterly D&A is now -96.88% below its all-time high of $128.10 thousand, reached on September 30, 2014.
Performance
ATOS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$27.00 K
+$1000.00+3.85%
September 30, 2024
Summary
- As of February 7, 2025, ATOS TTM depreciation & amortization is $27.00 thousand, with the most recent change of +$1000.00 (+3.85%) on September 30, 2024.
- Over the past year, ATOS TTM D&A has increased by +$16.00 thousand (+145.45%).
- ATOS TTM D&A is now -94.64% below its all-time high of $503.40 thousand, reached on September 30, 2014.
Performance
ATOS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ATOS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +187.5% | +33.3% | +145.4% |
| 3 y3 years | -51.1% | -33.3% | -12.1% |
| 5 y5 years | -48.0% | -33.3% | -12.1% |
ATOS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +187.5% | -71.4% | +100.0% | at high | +237.5% |
| 5 y | 5-year | -56.4% | +187.5% | -71.4% | +100.0% | -48.9% | +237.5% |
| alltime | all time | -95.2% | -100.0% | -96.9% | +144.4% | -94.6% | +1828.6% |
Atossa Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4000.00(0.0%) | $27.00 K(+3.8%) |
| Jun 2024 | - | $4000.00(-20.0%) | $26.00 K(+4.0%) |
| Mar 2024 | - | $5000.00(-64.3%) | $25.00 K(+8.7%) |
| Dec 2023 | $23.00 K(+187.5%) | $14.00 K(+366.7%) | $23.00 K(+109.1%) |
| Sep 2023 | - | $3000.00(0.0%) | $11.00 K(+10.0%) |
| Jun 2023 | - | $3000.00(0.0%) | $10.00 K(+11.1%) |
| Mar 2023 | - | $3000.00(+50.0%) | $9000.00(+12.5%) |
| Dec 2022 | $8000.00(-65.2%) | $2000.00(0.0%) | $8000.00(0.0%) |
| Sep 2022 | - | $2000.00(0.0%) | $8000.00(-33.3%) |
| Jun 2022 | - | $2000.00(0.0%) | $12.00 K(-25.0%) |
| Mar 2022 | - | $2000.00(0.0%) | $16.00 K(-30.4%) |
| Dec 2021 | $23.00 K(-51.1%) | $2000.00(-66.7%) | $23.00 K(-25.1%) |
| Sep 2021 | - | $6000.00(0.0%) | $30.70 K(-17.7%) |
| Jun 2021 | - | $6000.00(-33.3%) | $37.30 K(-14.6%) |
| Mar 2021 | - | $9000.00(-7.2%) | $43.70 K(-7.0%) |
| Dec 2020 | $47.00 K(-11.0%) | $9700.00(-23.0%) | $47.00 K(-5.6%) |
| Sep 2020 | - | $12.60 K(+1.6%) | $49.80 K(-0.2%) |
| Jun 2020 | - | $12.40 K(+0.8%) | $49.90 K(-2.3%) |
| Mar 2020 | - | $12.30 K(-1.6%) | $51.10 K(-3.2%) |
| Dec 2019 | $52.80 K(+19.5%) | $12.50 K(-1.6%) | $52.80 K(-5.4%) |
| Sep 2019 | - | $12.70 K(-6.6%) | $55.80 K(+3.3%) |
| Jun 2019 | - | $13.60 K(-2.9%) | $54.00 K(+7.1%) |
| Mar 2019 | - | $14.00 K(-9.7%) | $50.40 K(+13.8%) |
| Dec 2018 | $44.20 K(-65.7%) | $15.50 K(+42.2%) | $44.30 K(-20.5%) |
| Sep 2018 | - | $10.90 K(+9.0%) | $55.70 K(-24.4%) |
| Jun 2018 | - | $10.00 K(+26.6%) | $73.70 K(-23.9%) |
| Mar 2018 | - | $7900.00(-70.6%) | $96.80 K(-25.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $129.00 K(-57.5%) | $26.90 K(-6.9%) | $129.00 K(-27.6%) |
| Sep 2017 | - | $28.90 K(-12.7%) | $178.20 K(-20.5%) |
| Jun 2017 | - | $33.10 K(-17.5%) | $224.10 K(-16.3%) |
| Mar 2017 | - | $40.10 K(-47.3%) | $267.80 K(-11.7%) |
| Dec 2016 | $303.50 K(+11.3%) | $76.10 K(+1.7%) | $303.40 K(-8.5%) |
| Sep 2016 | - | $74.80 K(-2.6%) | $331.70 K(-10.3%) |
| Jun 2016 | - | $76.80 K(+1.5%) | $369.90 K(+30.2%) |
| Mar 2016 | - | $75.70 K(-27.5%) | $284.10 K(+4.2%) |
| Dec 2015 | $272.60 K(-43.2%) | $104.40 K(-7.6%) | $272.60 K(+1.9%) |
| Sep 2015 | - | $113.00 K(-1355.6%) | $267.50 K(-5.3%) |
| Jun 2015 | - | -$9000.00(-114.0%) | $282.60 K(-32.6%) |
| Mar 2015 | - | $64.20 K(-35.3%) | $419.40 K(-12.7%) |
| Dec 2014 | $480.30 K(+1.6%) | $99.30 K(-22.5%) | $480.30 K(-4.6%) |
| Sep 2014 | - | $128.10 K(+0.2%) | $503.40 K(+0.8%) |
| Jun 2014 | - | $127.80 K(+2.2%) | $499.20 K(+0.0%) |
| Mar 2014 | - | $125.10 K(+2.2%) | $499.10 K(+5.5%) |
| Dec 2013 | $472.90 K(+262.1%) | $122.40 K(-1.2%) | $472.90 K(+3.8%) |
| Sep 2013 | - | $123.90 K(-3.0%) | $455.50 K(+33.9%) |
| Jun 2013 | - | $127.70 K(+29.1%) | $340.10 K(+54.0%) |
| Mar 2013 | - | $98.90 K(-5.8%) | $220.90 K(+69.3%) |
| Dec 2012 | $130.60 K(+737.2%) | $105.00 K(+1135.3%) | $130.50 K(+276.1%) |
| Sep 2012 | - | $8500.00(0.0%) | $34.70 K(+11.2%) |
| Jun 2012 | - | $8500.00(0.0%) | $31.20 K(+29.5%) |
| Mar 2012 | - | $8500.00(-7.6%) | $24.10 K(+54.5%) |
| Dec 2011 | $15.60 K(>+9900.0%) | $9200.00(+84.0%) | $15.60 K(+143.8%) |
| Sep 2011 | - | $5000.00(+257.1%) | $6400.00(+357.1%) |
| Jun 2011 | - | $1400.00 | $1400.00 |
| Dec 2010 | $0.00 | - | - |
FAQ
- What is Atossa Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Atossa Therapeutics?
- What is Atossa Therapeutics annual D&A year-on-year change?
- What is Atossa Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly D&A year-on-year change?
- What is Atossa Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Atossa Therapeutics?
- What is Atossa Therapeutics TTM D&A year-on-year change?
What is Atossa Therapeutics annual depreciation & amortization?
The current annual D&A of ATOS is $23.00 K
What is the all time high annual D&A for Atossa Therapeutics?
Atossa Therapeutics all-time high annual depreciation & amortization is $480.30 K
What is Atossa Therapeutics annual D&A year-on-year change?
Over the past year, ATOS annual depreciation & amortization has changed by +$15.00 K (+187.50%)
What is Atossa Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ATOS is $4000.00
What is the all time high quarterly D&A for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly depreciation & amortization is $128.10 K
What is Atossa Therapeutics quarterly D&A year-on-year change?
Over the past year, ATOS quarterly depreciation & amortization has changed by +$1000.00 (+33.33%)
What is Atossa Therapeutics TTM depreciation & amortization?
The current TTM D&A of ATOS is $27.00 K
What is the all time high TTM D&A for Atossa Therapeutics?
Atossa Therapeutics all-time high TTM depreciation & amortization is $503.40 K
What is Atossa Therapeutics TTM D&A year-on-year change?
Over the past year, ATOS TTM depreciation & amortization has changed by +$16.00 K (+145.45%)